Clinical trials: CPA

Hirsutism, Androgenetic Alopecia

DUS on the Prescribing Indications for CPA/EE in 5 European Countries

• Completed
• Age: All ages
• Observational study
• Results posted

This study was designed to compile the reasons and specific indications for the prescription of Cyproterone Acetate combined with Ethinyl Estradiol by Health Care Providers.

Conditions

Hirsutism, Androgenetic Alopecia, Severe Anemia, Seborrhea

Trial name

NCT02494297

Where

Germany

Volunteers

1,597 people, healthy volunteers welcome

Sponsor

Center for Epidemiology and Health Research, Germany